300
Participants
Start Date
September 30, 1999
Study Completion Date
December 31, 2000
Inhaled human insulin (EXUBERA™)
Pfizer Investigational Site, Burlingame
Pfizer Investigational Site, Irvine
Pfizer Investigational Site, Los Angeles
Pfizer Investigational Site, Newport Beach
Pfizer Investigational Site, Orange
Pfizer Investigational Site, San Diego
Pfizer Investigational Site, San Francisco
Pfizer Investigational Site, Tustin
Pfizer Investigational Site, New Haven
Pfizer Investigational Site, Washington D.C.
Pfizer Investigational Site, Clearwater
Pfizer Investigational Site, Miami
Pfizer Investigational Site, Tampa
Pfizer Investigational Site, Chicago
Pfizer Investigational Site, Louisville
Pfizer Investigational Site, New Orleans
Pfizer Investigational Site, Columbia
Pfizer Investigational Site, St Louis
Pfizer Investigational Site, Omaha
Pfizer Investigational Site, New Hyde Park
Pfizer Investigational Site, New York
Pfizer Investigational Site, Rochester
Pfizer Investigational Site, Durham
Pfizer Investigational Site, Greenville
Pfizer Investigational Site, Winston-Salem
Pfizer Investigational Site, Cleveland
Pfizer Investigational Site, Portland
Pfizer Investigational Site, Austin
Pfizer Investigational Site, Dallas
Pfizer Investigational Site, Irving
Pfizer Investigational Site, San Antonio
Pfizer Investigational Site, Burlington
Pfizer Investigational Site, Charlottesville
Pfizer Investigational Site, Renton
Pfizer Investigational Site, Calgary
Pfizer Investigational Site, Edmonton
Pfizer Investigational Site, Red Deer
Pfizer Investigational Site, Winnipeg
Pfizer Investigational Site, St. John's
Pfizer Investigational Site, Halifax
Pfizer Investigational Site, Mississauga
Pfizer Investigational Site, Ottawa
Pfizer Investigational Site, Toronto
Pfizer Investigational Site, Chomedy
Pfizer Investigational Site, Montreal
Lead Sponsor
Pfizer
INDUSTRY